Merck KGaA Says Third-Quarter Profit ...

Merck KGaA Says Third-Quarter Profit Rises 7.5%, Beating Analyst Estimates

There are 1 comment on the Bloomberg story from Oct 26, 2011, titled Merck KGaA Says Third-Quarter Profit Rises 7.5%, Beating Analyst Estimates. In it, Bloomberg reports that:

Merck KGaA , the German maker of cancer drug Erbitux, reported third-quarter profit that beat analysts' estimates because of growth at the Merck Serono pharmaceutical and Millipore equipment businesses.

Join the discussion below, or Read more at Bloomberg.

Gary

Toronto, Canada

#1 Nov 1, 2011

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Scientific Instruments Discussions

Title Updated Last By Comments
Kitchen For Sale In Glasgow Area UK Oct '16 Anonymous 1
News OSI Systems's Sell Rating Reaffirmed at Benchma... (Dec '13) Jan '16 Human 35
News Microvision, Inc. (MVIS) Coverage Initiated at ... (Dec '15) Dec '15 emanresu 1
Simisometer (Jan '13) Aug '15 DC from LA 2
News EARTHQUAKES: University of Oklahoma developed q... (Jun '15) Jun '15 great 1
News 3D Systems: Weighing The Bankruptcy Risk (Mar '15) May '15 SuriJohn 2
News Oil tycoon Harold Hamm reportedly tried to get ... (May '15) May '15 bizness is biznes... 1
More from around the web